Recent insider trends for Bio-Path Holdings, Inc. (NASDAQ:BPTH) have caught the attention of investors. Insider activity is often a strong indicator of future performance in a stock, and if the data on BPTH is anything to go by, investors should pay attention.
Institutions own 15.15% of Bio-Path Holdings, Inc. (BPTH)’s shares. The total value of these holdings, in millions, is $5. Among active positions in the latest quarter, 18 holders increased their positions by a total of 4.49 million shares, 27 holders decreased the positions by a total of 7.65 million shares, and 7 holders held their positions. This works out to a net decrease in ownership of 3.17 million shares, and suggests that institutions are feeling bearish about the stock.
Among new and sold out positions, 9 holders initiated new positions by a total of 1.08 million shares and 13 holders exited their positions by a total of 1.04 million shares. This nets out to an increase of 44029 shares and is a bullish sign for BPTH.
Insider ownership increased by a total of 0 shares, which suggests that BPTH’s key executives are feeling more optimistic about the outlook for the stock. The data from the past twelve months tells a similar story: ownership increased by a net of 0 shares.
Short interest, or the number of a stock’s tradable shares currently being shorted, is another metric investors use to get a pulse on sentiment. Bio-Path Holdings, Inc. (NASDAQ:BPTH)’s short interest is 2.97 million shares, or 3.44% of the float. This represents an increase of 19% in the number of shares being shorted compared to the previous reading, and implies that investors felt more pessimistic about the stock during the past two weeks.
Insider data can help an investor form an outlook on a stock, but it’s important to supplement this data with other information such as technical indicators to form a more complete view. A composite of 13 technical indicators that includes measures such as moving averages and momentum oscillators suggests that BPTH is a sell, which implies that BPTH is expected to underperform the market based on prior trading patterns.
Institutional ownership trends suggest that the stock is cheap and the insider trading data indicates that insiders are bullish. Technical indicators (also) suggest that Bio-Path Holdings, Inc. (NASDAQ:BPTH) is overvalued.